- Home
- ALMU vs OCGN Comparison
ALMU vs OCGN Comparison
Compare ALMU & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMU
- OCGN
- Stock Information
- Founded
- ALMU 2019
- OCGN 2013
- Country
- ALMU United States
- OCGN United States
- Employees
- ALMU N/A
- OCGN N/A
- Industry
- ALMU Semiconductors
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALMU Technology
- OCGN Health Care
- Exchange
- ALMU Nasdaq
- OCGN Nasdaq
- Market Cap
- ALMU 247.7M
- OCGN 283.3M
- IPO Year
- ALMU N/A
- OCGN N/A
- Fundamental
- Price
- ALMU $20.82
- OCGN $0.99
- Analyst Decision
- ALMU Strong Buy
- OCGN Strong Buy
- Analyst Count
- ALMU 2
- OCGN 3
- Target Price
- ALMU $25.50
- OCGN $6.00
- AVG Volume (30 Days)
- ALMU 347.5K
- OCGN 3.7M
- Earning Date
- ALMU 08-15-2025
- OCGN 08-01-2025
- Dividend Yield
- ALMU N/A
- OCGN N/A
- EPS Growth
- ALMU N/A
- OCGN N/A
- EPS
- ALMU N/A
- OCGN N/A
- Revenue
- ALMU $3,627,488.00
- OCGN $4,754,000.00
- Revenue This Year
- ALMU N/A
- OCGN N/A
- Revenue Next Year
- ALMU N/A
- OCGN N/A
- P/E Ratio
- ALMU N/A
- OCGN N/A
- Revenue Growth
- ALMU 335.67
- OCGN N/A
- 52 Week Low
- ALMU $2.50
- OCGN $0.52
- 52 Week High
- ALMU $25.88
- OCGN $1.42
- Technical
- Relative Strength Index (RSI)
- ALMU N/A
- OCGN 45.53
- Support Level
- ALMU N/A
- OCGN $1.01
- Resistance Level
- ALMU N/A
- OCGN $1.11
- Average True Range (ATR)
- ALMU 0.00
- OCGN 0.07
- MACD
- ALMU 0.00
- OCGN -0.01
- Stochastic Oscillator
- ALMU 0.00
- OCGN 21.52
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").